查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765170

全球肾臟去神经支配技术市场

Renal Denervation Technologies
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 107 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球肾臟去神经支配技术市场规模将达到 31 亿美元

全球肾臟去神经支配技术市场规模预计在2024年达到3.783亿美元，预计在分析期内（2024-2030年）将以41.7%的复合年增长率增长，到2030年将达到31亿美元。射频技术是本报告分析的细分市场之一，预计其复合年增长率将达到41.3%，到分析期结束时将达到21亿美元。超音波技术细分市场在分析期间的复合年增长率预计为43.5%。

美国市场规模估计为 9,040 万美元，中国市场预计复合年增长率为 51.7%

美国肾臟去神经支配技术市场规模预计2024年达到9,040万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到2.499亿美元，在2024-2030年的分析期间内，复合年增长率为51.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为34.4%和38.0%。在欧洲，预计德国市场的复合年增长率约为38.4%。

全球肾臟去神经支配技术市场—主要趋势与驱动因素摘要

肾去神经支配技术是治疗难治性高血压的一项有希望的进展，难治性高血压是指儘管使用多种抗高血压药物，高血压仍然无法控制的疾病。这种微创手术涉及使用导管射频或超音波能量来消融肾臟动脉周围的肾神经。肾去神经支配旨在透过阻断透过这些神经传递的讯号来减少交感神经系统活动并降低血压。此手术通常在局部麻醉下进行，导管经由股动脉插入并引导至肾动脉进行标靶消融。这种手术不仅可以降低血压，还显示出产生持久益处的潜力，这使其成为传统治疗方法不够有效的患者的理想选择。

技术进步显着提高了肾臟去神经支配术的疗效和安全性。早期临床试验面临结果不一致的挑战，促使该技术进一步创新和改进。现代系统采用改良的导管设计，可提供更佳的导航和更精准的能量输送，最大限度地减少对周围组织的损伤，并改善患者预后。此外，影像和测绘技术的进步使得更精确地定位肾神经成为可能，从而实现有效消融。人们对非射频方法（例如超音波和化学消融）的兴趣也日益浓厚，这些方法各有优势，提供了替代方法。持续的研究和发展正在加深我们对高血压潜在生理机制的理解，并正在催生更有效、更个人化的肾臟去神经支配术策略。

肾臟去神经技术市场的成长受到多种因素的推动。全球高血压盛行率的上升，尤其是难治性高血压，是一个主要驱动因素，因为它刺激了对创新治疗方案的需求。医疗技术的进步和对高血压病理生理学的深入了解，促进了更有效、更安全的肾臟去神经系统的发展。全球人口老化，加上不良饮食和久坐不动等生活方式因素，导致高血压盛行率上升，进一步扩大了此类技术的潜在市场。此外，越来越多的临床证据支持肾臟去神经的长期益处和安全性，正在鼓励更多的医疗保健提供者采用这种治疗方法。现代医学推行微创手术，原因是患者偏好恢復期更短、併发症更少的治疗方法，这也支持了市场的成长。这些因素共同凸显了肾臟去神经技术市场的动态和快速发展。

部分

技术（基于射频、基于超音波、基于微输注）

受访公司范例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

人工智慧集成

利用检验的专家内容和 AI 工具转变您的市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 拉丁美洲
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP14407

Global Renal Denervation Technologies Market to Reach US$3.1 Billion by 2030

The global market for Renal Denervation Technologies estimated at US$378.3 Million in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 41.7% over the analysis period 2024-2030. Radiofrequency Based, one of the segments analyzed in the report, is expected to record a 41.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Ultrasound Based segment is estimated at 43.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$90.4 Million While China is Forecast to Grow at 51.7% CAGR

The Renal Denervation Technologies market in the U.S. is estimated at US$90.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$249.9 Million by the year 2030 trailing a CAGR of 51.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 34.4% and 38.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 38.4% CAGR.

Global Renal Denervation Technologies Market - Key Trends & Drivers Summarized

Renal denervation technologies represent a promising advancement in the treatment of resistant hypertension, a condition where high blood pressure remains uncontrolled despite the use of multiple antihypertensive medications. This minimally invasive procedure involves the use of catheter-based radiofrequency or ultrasound energy to ablate the renal nerves, which are located around the arteries leading to the kidneys. By disrupting the signals transmitted through these nerves, renal denervation aims to reduce sympathetic nervous system activity, thereby lowering blood pressure. The procedure is typically performed under local anesthesia and involves the insertion of a catheter through the femoral artery, guided to the renal arteries, where targeted ablation is conducted. The technique has shown potential not only in reducing blood pressure but also in offering sustained effects, making it an attractive option for patients who do not respond adequately to conventional therapies.

Technological advancements have significantly enhanced the efficacy and safety of renal denervation procedures. Early clinical trials faced challenges with inconsistent results, prompting further innovation and refinement in the technology. Modern systems now offer improved catheter designs with better navigability and precision in delivering energy, which minimizes damage to surrounding tissues and enhances patient outcomes. Additionally, advancements in imaging and mapping technologies allow for more accurate targeting of the renal nerves, ensuring effective ablation. There has also been a growing interest in non-radiofrequency methods, such as ultrasound and chemical ablation, which provide alternative approaches with their own unique benefits. Continuous research and development are expanding the understanding of the physiological mechanisms underlying hypertension, leading to more effective and tailored renal denervation strategies.

The growth in the renal denervation technologies market is driven by several factors. The increasing prevalence of hypertension worldwide, particularly resistant hypertension, is a major driver, as it fuels the demand for innovative treatment options. Advances in medical technology and a deeper understanding of the pathophysiology of hypertension have led to the development of more effective and safer renal denervation systems. The aging global population, coupled with lifestyle factors such as poor diet and sedentary behavior, contributes to the rising incidence of hypertension, further expanding the potential market for these technologies. Additionally, the growing body of clinical evidence supporting the long-term benefits and safety of renal denervation is encouraging more healthcare providers to adopt this treatment modality. The push for minimally invasive procedures in modern medicine, driven by patient preference for treatments with shorter recovery times and fewer complications, also supports market growth. These factors collectively highlight the dynamic and rapidly evolving nature of the renal denervation technologies market.

SCOPE OF STUDY:

The report analyzes the Renal Denervation Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Radiofrequency Based, Ultrasound Based, Micro-Infusion Based)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Renal Denervation Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Hypertension - A Chronic Disease
    • A Prelude to Renal Denervation
    • The Evolution
    • Global Renal Denervation Technologies Market Set to Witness Rapid Growth
    • Developed Regions Dominate, Asia-Pacific Exhibits Fastest Growth
    • Europe - A Major Market
    • Radiofrequency Ablation Dominates the Market, Ultrasound to Register Fastest Growth
    • Radiofrequency Based Renal Denervation
    • Ultrasound Based Renal Denervation
    • Micro-Infusion Based Renal Denervation
    • Stringent Regulatory Environment
    • Growth Deterrents
    • Competitive Landscape
    • Select List of Approved Renal Denervation Devices
    • Symplicity Renal Denervation System Leads
    • Renal Denervation Devices
    • EnligHTN
    • Iberis
    • Paradise
    • Symplicity
    • Vessix (V2)
    • Recent Market Activity
    • Recent Clinical Trials in Nerve Denervation Technologies
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Hypertension Drives the Market for Renal Denervation Technologies Market
    • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
    • Ageing Demographics to Propel the Demand for Renal Denervation Devices
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Rising Obesity Incidence Spurs the Demand for Renal Denervation Technologies Market
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • Regulatory Approvals to Remain a Focal Point
    • Breakthrough Designations for Renal Denervation Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiofrequency Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Radiofrequency Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Ultrasound Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Micro-Infusion Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Micro-Infusion Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2025 & 2030
    • TABLE 9: World Renal Denervation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 10: USA Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 11: USA 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • CANADA
    • TABLE 12: Canada Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 13: Canada 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • JAPAN
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 14: Japan Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Japan 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • CHINA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 16: China Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: China 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • EUROPE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 18: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: Europe 6-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Europe 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • FRANCE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 22: France Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: France 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • GERMANY
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 24: Germany Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Germany 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • ITALY
    • TABLE 26: Italy Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Italy 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • UNITED KINGDOM
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 28: UK Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: UK 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • SPAIN
    • TABLE 30: Spain Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Spain 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • RUSSIA
    • TABLE 32: Russia Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Russia 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • LATIN AMERICA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 38: Latin America Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Latin America 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 40: Rest of World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Rest of World 6-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2025 & 2030

IV. COMPETITION